BiomX Past Earnings Performance

Past criteria checks 0/6

BiomX's earnings have been declining at an average annual rate of -4.9%, while the Biotechs industry saw earnings growing at 19.1% annually.

Key information

-4.9%

Earnings growth rate

49.9%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equity-95.7%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

What Kind Of Shareholders Own BiomX Inc. (NYSEMKT:PHGE)?

Jan 29
What Kind Of Shareholders Own BiomX Inc. (NYSEMKT:PHGE)?

Revenue & Expenses Breakdown

How BiomX makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:PHGE Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-261018
31 Mar 240-341015
31 Dec 230-261016
30 Sep 230-27916
30 Jun 230-251014
31 Mar 230-271015
31 Dec 220-281115
30 Sep 220-331119
30 Jun 220-361222
31 Mar 220-361221
31 Dec 210-361222
30 Sep 210-351222
30 Jun 210-341121
31 Mar 210-331021
31 Dec 200-301019
30 Sep 200-271118
30 Jun 200-231115
31 Mar 200-221014
31 Dec 190-21913
30 Sep 190-22511
30 Jun 190-19411
31 Mar 190-17410
31 Dec 180-1539
31 Dec 170-734

Quality Earnings: PHGE is currently unprofitable.

Growing Profit Margin: PHGE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PHGE is unprofitable, and losses have increased over the past 5 years at a rate of 4.9% per year.

Accelerating Growth: Unable to compare PHGE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PHGE is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.3%).


Return on Equity

High ROE: PHGE has a negative Return on Equity (-95.73%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies